Pfizer Q3FY22 PAT at Rs 143.91 crore

Pfizer Q3FY22 PAT at Rs 143.91 crore

By: IPP Bureau

Last updated : February 04, 2022 8:51 am



The company has reported standalone financial results for the period ended December 31, 2021.


Financial results (Q3 FY2022) - QoQ comparison

 The company has reported a total income of Rs. 694.16 crore during the period ended December 31, 2021 as compared to Rs. 651.29 crore during the period ended September 30, 2021. 

The company has posted a net profit of Rs. 143.91 crore for the period ended December 31, 2021 as against a net profit of Rs. 142.95 crores for the period ended September 30, 2021.

Financial results (Q3 FY2022) - YoY comparison

The company has reported total income of Rs. 694.16 crore during the period ended December 31, 2021 as compared to Rs.608.06 crore during the period ended December 31, 2020. 

The company has posted a net profit of Rs.143.91 crore for the period ended December 31, 2021 as against a net profit of Rs.141.24 crore for the period ended December 31, 2020. 

Financial results (nine-month ended FY2022) - YoY comparison

The company has reported total income of Rs.2106.86 crores during the nine-month period ended December 31, 2021 as compared to Rs.1747.71 crores during the nine-month period ended December 31, 2020.

The company has posted a net profit of Rs.486.77 crore for the nine-month period ended December 31, 2021 as against a net profit of Rs.397.06 crore for the nine-month period ended December 31, 2020.

 

Pfizer

First Published : February 04, 2022 12:00 am